258 related articles for article (PubMed ID: 19617208)
1. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial.
Scarpellini F; Sbracia M
Hum Reprod; 2009 Nov; 24(11):2703-8. PubMed ID: 19617208
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage.
Santjohanser C; Knieper C; Franz C; Hirv K; Meri O; Schleyer M; Würfel W; Toth B
Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):159-64. PubMed ID: 23344173
[TBL] [Abstract][Full Text] [Related]
4. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
[TBL] [Abstract][Full Text] [Related]
5. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
[TBL] [Abstract][Full Text] [Related]
6. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
7. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
11. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
[TBL] [Abstract][Full Text] [Related]
13. Is granulocyte colony-stimulating factor level predictive for human IVF outcome?
Salmassi A; Schmutzler AG; Schaefer S; Koch K; Hedderich J; Jonat W; Mettler L
Hum Reprod; 2005 Sep; 20(9):2434-40. PubMed ID: 15890733
[TBL] [Abstract][Full Text] [Related]
14. Recurrent miscarriage: current concepts in diagnosis and treatment.
Toth B; Jeschke U; Rogenhofer N; Scholz C; Würfel W; Thaler CJ; Makrigiannakis A
J Reprod Immunol; 2010 May; 85(1):25-32. PubMed ID: 20185181
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome in women with factor V Leiden and recurrent miscarriage.
Jivraj S; Makris M; Saravelos S; Li TC
BJOG; 2009 Jun; 116(7):995-8. PubMed ID: 19522801
[TBL] [Abstract][Full Text] [Related]
16. Supportive care for women with unexplained recurrent miscarriage: patients' perspectives.
Musters AM; Taminiau-Bloem EF; van den Boogaard E; van der Veen F; Goddijn M
Hum Reprod; 2011 Apr; 26(4):873-7. PubMed ID: 21317153
[TBL] [Abstract][Full Text] [Related]
17. The possible role of classical human leukocyte antigens in recurrent miscarriage.
Christiansen OB
Am J Reprod Immunol; 1999 Aug; 42(2):110-5. PubMed ID: 10476693
[TBL] [Abstract][Full Text] [Related]
18. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy.
Yan J; Sripada S; Saravelos SH; Chen ZJ; Egner W; Li TC
Fertil Steril; 2012 Aug; 98(2):378-82. PubMed ID: 22624672
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand.
Cheng AC; Limmathurotsakul D; Chierakul W; Getchalarat N; Wuthiekanun V; Stephens DP; Day NP; White NJ; Chaowagul W; Currie BJ; Peacock SJ
Clin Infect Dis; 2007 Aug; 45(3):308-14. PubMed ID: 17599307
[TBL] [Abstract][Full Text] [Related]
20. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
